The FDA’s cybersecurity bill of materials has major implications – both good and bad – for healthcare provider organizations’ IT and security teams.
The draft bill of materials guidance is aimed at having manufacturers disclose other vendors’ software they may be using in addition to their own software/firmware. The intent is to give the IT security staff more context on the device software.